Related Experiment Video
Updated: Jun 16, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Current and emerging therapies for acute myeloid leukemia
Tadeusz Robak1, Agnieszka Wierzbowska
1Department of Hematology, Medical University of Lodz, Copernicus Memorial Hospital, Lodz, Poland. robaktad@csk.umed.lodz.pl
Clinical Therapeutics
|January 30, 2010
Summary
Cytarabine (AraC) and anthracyclines remain standard for acute myeloid leukemia (AML) induction. High-dose AraC is standard consolidation for AML patients under 60, though new agents show promise in combination therapies.
Area of Science:
- Hematology
- Oncology
- Clinical Trials
Background:
- Acute myeloid leukemia (AML) is a bone marrow malignancy with increasing incidence and poorer outcomes in older patients.
- Nonpromyelocytic AML presents unique challenges, particularly in patients under 60 years old.
Purpose of the Study:
- To review current and emerging treatment strategies for nonpromyelocytic AML in patients under 60.
- To analyze the efficacy of established and novel therapeutic approaches.
Main Methods:
- Comprehensive literature review of PubMed and conference proceedings (1990-2009).
- Inclusion of clinical trials for adults aged 19 years and older.
- Search terms included AML, treatment, chemotherapy, stem cell transplantation, and immunotherapy.
Main Results:
- Cytarabine (AraC) plus anthracyclines form the basis of induction therapy.
- High-dose AraC is standard consolidation for AML patients under 60.
- Allogeneic stem cell transplantation is effective for relapsed or refractory AML.
- Numerous novel agents are under investigation, including immunotoxins and tyrosine kinase inhibitors.
Conclusions:
- Standard induction and consolidation therapies for AML in younger patients remain critical.
- Novel agents are likely to be most effective in combination with existing treatments or other new drugs.
- Well-designed clinical trials are essential for evaluating new AML therapies.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...